3[3]Northway WH Jr,Rosan RC,Porter DY.Pulmonary disease following respirator therapy of hyaline-membrane disease.Bronchopulmonary dysplasia[J].N Engl J Med,1967,276(7):357-368.
4[4]Shennan AT,Dunn MS,Ohlsson A,Lennox K,Hoskins EM.Abnormal pulmonary outcomes in premature infants:prediction from oxygen requirement in the neonatal period[J].Pediatrics,1988,82 (4):527-532.
5[5]Jobe AH,Bancalari E.Bronchopulmonary dysplasia[J].Am J Respir Crit Care Med,2001,163 (7):1723-1729.
6[6]Ehrenkranz RA,Walsh MC,Vohr BR,Jobe AH,Wright LL,Fanaroff AA,et al.Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia[J].Pediatrics,2005,116 (6):1353-1360.
7[7]Walsh MC,Yao Q,Gettner P,Hale E,Collins M,Hensman A,et al.Impact of a physiologic definition on bronchopulmonary dysplasia rates[J].Pediatrics,2004,114 (5):1305-1311.
8[8]Walsh MC,Wilson-Costello D,Zadell A,Newman N,Fanaroff A.Safety,reliability,and validity of a physiologic definition of bronchopulmonary dysplasia[J].J Perinatol,2003,23 (6):451-456.
9[9]Thomas W,Speer CP.Management of infants with bronchopulmonary dysplasia in Germany[J].Early Hum Dev,2005,81 (2):155-163.
10[10]Tyson JE,Wright LL,Oh W,Kennedy KA,Mele L,Ehrenkranz RA,et al.Vitamin A supplementation for extremely-low-birthweight infants.National Institute of Child Health and Human Development Neonatal Research Network[J].N Engl J Med,1999,340 (25):1962-1968.
4Saizon C, Sachs P, Benbayoun M, et al. Antenatal corticosteroids: benefits and risks[ J]. J Gynecol Obstet Biol Reprod( Paris) ,2005,34 ( suppl 1 ) :s111-117.
5Lee BH,Stoll BJ,Medonald SA,et al. National Institute of Child Health and Human Development Neonatal Research Network:adverse neonatal outcomes associated with antinatal dexamethasone versus betamethasone [ J ]. Pediatrics, 2006, 117 ( 5 ) : 1503- 1516.
6Wapner RJ,Sorokin Y,Mele L, et al. National Institute of Child Health and Human Development Maternal-Fetal Medcine Unit Network :long-term outcomes after repeat doses of antenatal corticosteroids[ J ]. N Engl J Med ,2007,357 (12) : 1190-1198.
7Miksch RM, Armbrust S, Pahnke J, et al. Outcome of very low birth weight infants after introducing a new standard regime with the early use of nasal CPAP [ J ] . Eur J Pediatr, 2008, Jan 3 (Epub ahead print).
8Owen KS, Morley C J, Davis PG. Neonatal nasal intermittent positive pressure ventilation : what do we know in 2007 [ J ] . Arch Dis Child Fetal Neonatal Ed,2007,92 ( 5 ) : F414-418.
9Hutchison AA, Bignall S. Non-invasive positive pressure ventilation in the preterm neonate: reducing endotrauma and the incidence of bronchopulmonary dysplasia [ J ]. Arch Dis Child Fetal Neonatal Ed ,2008,93 ( 1 ) :F64-68.
10Horst SA,Wagenar GT, De Boer E, et al. Pentoxifylline reduce fibrin deposition and prolongs survival in neonatal hyperoxic lung injury [ J ]. J Appl Physiol, 2004,97 ( 5 ) :2014 -2019.
